SPARK Norway project lays the foundation for a new biotech company_篮球即时比分_nba比分直播-彩客网重点推荐

2021-06-03T11:50:10.102Z
type:structured-article
www.uio.no

Recently the new biotech company Tribune Therapeutics was established based on research conducted by Ole J?rgen Kaasb?ll and H?vard Attramadal. Ole J?rgen Kaasb?ll was admitted to UiO:Life Science’ innovation programme SPARK Norway in 2019 and will now assume the role of Chief Scientific Officer in the new company where Georg Vo Beiske, HealthCap has been appointed Chief Executive Officer. Tribune Therapeutics aims to develop a treatment for fibrosis.